Sunifiram Nootropics

Sunifiram Nootropics represent a cutting-edge cognitive enhancement compound designed to support optimal brain function and mental performance. This premium nootropic substance functions as a potent AMPA receptor agonist, directly targeting key neurological pathways involved in learning and memory processes. Manufactured to exceptional purity standards, it serves as an ideal ingredient for advanced cognitive formulations.

1. Data on Solubility
Sunifiram is a lipophilic chemical that functions well in organic solvents but has little solubility in water.

• Water: Low solubility (less than 5 mg/mL). It is commonly characterized as "sparingly soluble" in aqueous solutions that are neutral.
• DMSO: Highly soluble (≥ 30 mg/mL). When making high-concentration stock solutions, this is the recommended solvent.
• Ethanol: Soluble (15–20 mg/mL).
• DMF: 25 mg/mL is soluble.

Lipid Phase: Soluble in Medium-Chain Triglycerides (MCT oil), which is frequently utilized to improve absorption rates in oral formulation research and development.

2. Range of Melting Points
At room temperature, sunifiram is a stable crystalline solid.

• Melting point: 101.0°C to 103.0°C.
• Thermal Stability: It is reasonably stable under typical laboratory circumstances, but to avoid the piperazine ring being degraded, it should be maintained away from strong oxidizing agents and extremely high temperatures.

3. Information on Nuclear Magnetic Resonance (NMR)
Sunifiram's fundamental structure is 1-benzoyl-4-propanoylpiperazine, and its molecular formula is C14H18N2O2.1H-NMR (CDCl3, 400 MHz)
Note: Peak splitting or overlap brought on by cis-trans isomerism may be seen as a result of the amide bonds' limited rotation.

13C-NMR(100 MHz, CDCl3)

• 172.5 ppm: Carbonyl carbon of the propanoyl group (-N-C=O)
• 170.6 ppm: Carbonyl carbon of the benzoyl group (-N-C=O)
• 135.2 ppm: Quaternary aromatic carbon (C1)
• 130.1 ppm: Aromatic CH (Para position)
• 128.6 ppm: Aromatic CH (Meta positions)
• 127.1 ppm: Aromatic CH (Ortho positions)
• 41.0 - 46.5 ppm: Methylene carbons of the piperazine ring (often showing multiple overlapping peaks due to amide isomerism)
• 26.4 ppm: Propanoyl methylene carbon (-CH2-)
• 9.2 ppm: Propanoyl methyl carbon (-CH3)

The physical and chemical characteristics of Sunifiram (DM-235) pose unique hurdles in pharmaceutical research and development, especially with regard to potency and sensory attributes. Despite having a relatively basic structure, the formulation process must be quite precise due to its high activity.
The four main obstacles to Sunifiram development are as follows, along with the answers for each:

1. Uniformity of Content at Extremely Low Doses
The Problem:

Sunifiram's suggested dosage is extremely low, usually between 5 and 10 mg. Achieving complete homogeneity of the Active Pharmaceutical Ingredient (API) within a high amount of excipients is challenging when producing big batches of tablets or capsules. This may result in "hot spots," when dangerously high dosages are present in specific units.

The Solution:

• The gold-standard manual method, known as geometric dilution, involves gradually mixing the API with an equal volume of excipient.
• Micronization: When Sunifiram's particle size is reduced to less than 10 mum, there are more particles per unit of weight, which raises the statistical likelihood of a uniform distribution.
• Wet Granulation: The most dependable industrial technique to guarantee consistency for low-dose medications is to dissolve the API in a binder solution and spray it onto the excipient bed.

2. Serious Sensory Difficulties (High Bitterness)
The Problem:

Sunifiram has a strong, persistent chemical bitterness. If the dosage were a typical oral liquid or chewable tablet, patient compliance would be extremely low due to the little dosage.
The Solution:

• Film Coating: Using a moisture-barrier and taste-masking coat (such as Eudragit E100 or Opadry) guarantees that the medication dissolves quickly in the stomach rather than being discharged in the mouth.
• Cyclodextrin Inclusion: The bitterness at the molecular level is concealed by encasing Sunifiram molecules in a hydrophobic cavity using γ-Cyclodextrin or HP-γ-CD.
• Lipid Suspensions: By dissolving the API in MCT oil with other flavorings, a lipid barrier is created that lessens the API's interaction with taste buds.

3. Polymorphic Stability and Isomerism
The Problem:
An equilibrium of cis/trans isomers (E/Z isomers) in both solution and solid states may result from the structure's two amide bonds' limited rotation. Furthermore, piperazine derivatives frequently show polymorphism; variations in stability and solubility between crystal forms may cause precipitation or alter dissolving rates over the course of the shelf life.
The Solution:

• Crystallization Process Control: To guarantee that the product stays in a single, stable crystalline form, strictly regulate the cooling rate and recrystallization solvent system (e.g., ethanol/water ratio).
• XRPD Monitoring: To ensure that no polymorphic alteration has taken place, regularly perform X-Ray Powder Diffraction (XRPD) during stability testing (High Humidity/High Temp).

4. Increasing the Rate of Dissolution
The Problem:

Sunifiram dissolves in water somewhat slowly, even if it is not entirely insoluble. Slow dissolving might result in a delayed time to peak concentration (T_max) for nootropic drugs, where a quick beginning of effect is frequently required.
The Solution:

• Solid Dispersions: The dissolution rate can be greatly increased by dispersing Sunifiram in an amorphous state using hydrophilic polymers (such PVP K30 or PEG 6000) as carriers.
• Surfactants: Adding tiny amounts of Tween-80 or sodium dodecyl sulfate (SDS) to the mixture lowers surface tension and speeds up the soaking of the hydrophobic medication powder.

Sunifiram operates through sophisticated neurological mechanisms:

• Functions as an AMPA receptor agonist
• Enhances signaling at brain AMPA receptors
• Stimulates glutamate receptor activity
• Increases acetylcholine production and release
• Crosses the blood-brain barrier effectively
• Strengthens neural signals in the hippocampus

This advanced nootropic compound demonstrates multiple cognitive advantages:

• Enhanced learning and memory abilities
• Improved concentration and focus
• Increased mental energy and clarity
• Better memory retention and recall
• Enhanced synaptic plasticity
• Improved motivation and mental performance

Sunifiram Nootropics offer significant characteristics:

• Direct AMPA receptor activation
• Neurotransmitter modulation
• Hippocampal function enhancement
• Neural signal strengthening
• Cognitive function optimization

Dietary supplement formulations

Cognitive enhancement products

Learning and memory support

Mental performance optimization

Neuroplasticity enhancement

Current applications focus on:

• Rapid intercellular communication enhancement
• Spatial navigation improvement
• Memory formation and storage support
• Long-term neural enhancement
• Cognitive function research

Our production standards ensure:

• Consistent 99% purity levels
• Rigorous quality control measures
• Proper storage condition maintenance
• Reliable batch-to-batch consistency
• Comprehensive quality documentation

Our products have successfully entered the global market and are widely used by internationally renowned brands in the pharmaceutical, health supplement, cosmetics, animal nutrition, and functional food industries. As a supplier with over 15 years of experience, our company offers approximately 2,000 plant extracts. We focus on core technology research and development, holding multiple invention patents and relying on a team of professors and industry experts to ensure the international competitiveness of our products under a rigorous quality certification system.

Higher standards, more reassuring protection

Hot Tags: sunifiram nootropics, China sunifiram nootropics factory, Calcium Hopantenate Hemihydrate, hbt1, β nicotinamide mononucleotide, SLU PP 332 Powder, nicotinamide Mononucleotide, Pure Melatonin 20 Mg